Off-label promotions of diabetes meds sometimes nonsensical, watchdog warns FDA
By
John Hall
Apr 02, 2015
The nation’s leading consumer watchdog is asking the Food and Drug Administration to prohibit direct-to-consumer diabetes drug advertising promoting unapproved off-label benefits like weight and...
Higher dose of Alzheimer’s drug approved despite FDA warnings, report shows
By
McKnight's Staff
Mar 26, 2012
Makers of the Alzheimer’s drug Aricept released a higher dosage version of the medication despite concerns about side effects and reduced efficacy, a study reports.
